Dermavant Sciences: Dermavant Announces Appointment of Michael Swartzburg as Chief Financial Officer
Dermavant Sciences: Dermavant Announces Appointment of Michael Swartzburg as Chief Financial Officer - Over 20 Years of Combined Experience in Global Finance Leadership, Audit, and Advisory Roles in the Biopharmaceutical Industry - Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced the appointment of Michael Swartzburg as Chief Financial Officer. Mr. Swartzburg brings extensive...
United States Laurence Watts Los Angeles Kostenloser Wertpapierhandel Michael Swartzburg Angela Salerno Robin
Source: finanznachrichten.de